These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6334979)

  • 1. [Serotonin metabolism in severe depression. Clinical and biochemical changes and the contribution of precursors].
    Pérez de los Cobos Peris JC
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1984; 12(4):247-57. PubMed ID: 6334979
    [No Abstract]   [Full Text] [Related]  

  • 2. Instability in the response to DST in major depressions during treatment with 5-hydroxytryptophan and carbidopa.
    Lopez-Ibor JJ; Saiz-Ruiz J; Perez de los Cobos JC
    Acta Psychiatr Belg; 1985; 85(3):450-8. PubMed ID: 3876688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of myoclonus with L-5-hydroxytryptophan and carbidopa: clinical, electrophysiological, and biochemical observations.
    Thal LJ; Sharpless NS; Wolfson L; Katzman R
    Ann Neurol; 1980 Jun; 7(6):570-6. PubMed ID: 6969054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in the hypothalamo-pituitary-adrenal axis and the metabolism of serotonin in affective disorders. Therapeutic use of serotonin precursors (review)].
    Pérez de los Cobos Peris J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1986; 14(3):147-274. PubMed ID: 3526823
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa.
    Van Woert MH; Rosenbaum D; Howieson J; Bowers MB
    N Engl J Med; 1977 Jan; 296(2):70-5. PubMed ID: 401457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palatal myoclonus: treatment with 5-hydroxytryptophan and carbidopa.
    Bhatt M; Snow B; Varelas M; Calne D
    Mov Disord; 1990; 5(4):339-40. PubMed ID: 2259361
    [No Abstract]   [Full Text] [Related]  

  • 7. [5-hydroxytryptophan in combination with allopurinol in depressions].
    Calandra C; Zappalà E; Bonomo V; Rapisarda V
    Minerva Psichiatr; 1981; 22(3):131-5. PubMed ID: 6975867
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical trial with oxytryptan in depressions].
    Ruiz Ruiz M; Herrera D; Buil R; Lafuente M; Samada P; Zeledón F; Lillo JL
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1981; 9(4):325-30. PubMed ID: 7032243
    [No Abstract]   [Full Text] [Related]  

  • 9. l-5-Hydroxytryptophan in depression: the first substitution therapy in psychiatry? The treatment of 99 out-patients with 'therapy-resistant' depressions.
    van Hiele LJ
    Neuropsychobiology; 1980; 6(4):230-40. PubMed ID: 6967194
    [No Abstract]   [Full Text] [Related]  

  • 10. Serotonin precursors in the treatment of depression.
    van Praag HM
    Adv Biochem Psychopharmacol; 1982; 34():259-86. PubMed ID: 6753514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotransmitter precursors for the treatment of depression.
    Gelenberg AJ; Gibson CJ; Wojcik JD
    Psychopharmacol Bull; 1982 Jan; 18(1):7-18. PubMed ID: 6124021
    [No Abstract]   [Full Text] [Related]  

  • 12. [Catecholaminergic and serotoninergic systems in depression].
    Puzhin'skiĭ S; Bidzin'skiĭ A; Gauptmann M; Rode A; Zaluska M
    Vestn Akad Med Nauk SSSR; 1982; (1):66-8. PubMed ID: 7064535
    [No Abstract]   [Full Text] [Related]  

  • 13. Manipulation of brain serotonin in the treatment of myoclonus.
    Chadwick D; Jenner P; Harris R; Reynolds EH; Marsden CD
    Lancet; 1975 Sep; 2(7932):434-5. PubMed ID: 51240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New treatments for depression.
    Kent S
    Geriatrics; 1982 Nov; 37(11):149-51. PubMed ID: 6982191
    [No Abstract]   [Full Text] [Related]  

  • 15. In search of the mode of action of antidepressants: 5-HTP/tyrosine mixtures in depression.
    van Praag HM
    Adv Biochem Psychopharmacol; 1984; 39():301-14. PubMed ID: 6380226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Executive functions and serotonin activity in patients with depression. A connection mirrors the influence of serotonin on prefrontal cortex].
    Degl'Innocenti A; Agren H; Sjögren M; Zachrisson O; Bäckman L
    Lakartidningen; 1999 Nov; 96(45):4918-9. PubMed ID: 10596531
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hydroxytryptophan (oxitriptan) associated with classical antidepressants: an additional therapeutic possibility].
    Calanca A
    Schweiz Rundsch Med Prax; 1988 Aug; 77(34A):47-50. PubMed ID: 3263678
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of depression with L-5-hydroxytryptophan combined with chlorimipramine, a double-blind study.
    Nardini M; De Stefano R; Iannuccelli M; Borghesi R; Battistini N
    Int J Clin Pharmacol Res; 1983; 3(4):239-50. PubMed ID: 6381336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonergic approaches to the modification of behavior in the Lesch-Nyhan Syndrome.
    Nyhan WL; Johnson HG; Kaufman IA; Jones KL
    Appl Res Ment Retard; 1980; 1(1-2):25-40. PubMed ID: 6978104
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sclerodermiform and poikilodermic syndrome during treatment with carbidopa and 5-hydroxytryptophan. Culture of fibroblasts with biochemical analysis of collagen metabolism].
    Chamson A; Périer C; Frey J
    Ann Dermatol Venereol; 1986; 113(1):71. PubMed ID: 3486623
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.